NDC 47781-565 – Lisdexamfetamine dimesylate

Lisdexamfetamine Dimesylate 40 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CII

Product NDC47781-565

Product details

Brand name
Lisdexamfetamine dimesylate
Generic name
Lisdexamfetamine dimesylate
Labeler
Alvogen Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA214547
Marketed since
August 25, 2023
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Lisdexamfetamine dimesylate →

Package NDC codes (1)

Package NDCDescriptionSince
47781-565-01100 CAPSULE in 1 BOTTLE (47781-565-01)Aug 25, 2023

Other Lisdexamfetamine dimesylate products